Molbio Diagnosti Q1 FY27 Results (NSE: MOLBIO)
Signal: Loss reversed
The read
The main inflection is the return to profitability from a ₹239.44 million consolidated loss and ₹237.14 million owners' loss a year ago, but the -27.2% sequential revenue decline and ₹106.99 million finance cost require confirmation that the recovery is durable rather than a low-base rebound.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹408.38 Cr | +309.6% | -27.2% |
| EBIT | ₹86.61 Cr | N/A | |
| Net profit | ₹58.75 Cr | N/A (prior-year loss) | |
| EPS | ₹5.21 | N/A (prior-year loss) | |
| EBIT margin | 25.4% |
P&L walk
Consolidated revenue rose to ₹4,083.76 million from ₹997.08 million, while EBITDA margin was 25.4%; the recovery was helped by lower raw-material intensity, although finance cost rose to ₹106.99 million and non-controlling interest reduced reported group profit to ₹527.44 million versus owners' profit of ₹587.47 million.
Segments
The standalone parent generated ₹3,993.78 million of the ₹4,083.76 million consolidated revenue and ₹566.27 million of standalone profit versus ₹587.47 million attributable to owners, so the consolidated uplift was modest while non-controlling interests reduced total group profit by ₹60.03 million.
Key positives
- Consolidated revenue increased to ₹4,083.76 million from ₹997.08 million, a +309.6% YoY recovery from the prior-year loss quarter.
- Standalone gross margin expanded 554bps YoY to 63.87% as raw-material and component cost fell to 31.8% of revenue from 88.8%.
- Consolidated EBITDA margin was 25.4% and standalone EBITDA margin was 23.3%, with current-quarter EBITDA of ₹1,036.80 million and ₹930.00 million respectively.
- Standalone profit recovered to ₹566.27 million from a ₹134.05 million loss, showing that the parent business itself drove the turnaround.
Key concerns
- Consolidated revenue declined 27.2% QoQ to ₹4,083.76 million, while owners' profit declined 35.3% QoQ to ₹587.47 million.
- Finance cost increased 196.1% YoY to ₹106.99 million consolidated and 358.8% YoY to ₹86.62 million standalone.
- Consolidated gross margin declined 137bps YoY to 63.35%, and the filing does not disclose whether the change reflects pricing, mix, or input-cost movements.
- Non-controlling interests recorded a ₹60.03 million loss, reducing consolidated profit for the period to ₹527.44 million versus ₹587.47 million attributable to owners.
Research and educational content only. Not investment advice.